SM

Suma Mallikarjun Hulikantimath

Active Director Director DIN 11783856
DIN 11783856 First appointment Jun 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jun 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Suma Mallikarjun Hulikantimath

Data last updated:

Suma Mallikarjun Hulikantimath is a Director at Bridge Pharma Infinity Private Limited (since 2026) and Designated Partner at Astravion Pharmaceuticals Llp (since 2026).

DIN 11783856
Primary Designation Director
First Appointment 22 Jun 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jul 20262026Active
Designated Partner22 Jun 20262026Active

Directorship timeline

Open interactive timeline →
Astravion Pharmaceuticals Llp
Bridge Pharma Infinity Private Limited
Premium access

Shareholding and investment profile for Suma Mallikarjun Hulikantimath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suma Mallikarjun Hulikantimath

Suma Mallikarjun Hulikantimath currently holds 2 directorships: Bridge Pharma Infinity Private Limited (Director, since 07 Jul 2026); Astravion Pharmaceuticals Llp (Designated Partner, since 22 Jun 2026).

Suma Mallikarjun Hulikantimath was first appointed on 22 Jun 2026 as Designated Partner at Astravion Pharmaceuticals Llp.

The current boards of Suma Mallikarjun Hulikantimath's companies include Roopa (Bridge Pharma Infinity Private Limited), Bharatesh Kidambi (Bridge Pharma Infinity Private Limited), Medipalli Ambedkar Sastri (Bridge Pharma Infinity Private Limited), Nagaratna Shastrimath (Bridge Pharma Infinity Private Limited), Rashmi Rudragouda Patil (Bridge Pharma Infinity Private Limited), Usha Kidambi (Bridge Pharma Infinity Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available